Literature DB >> 8485073

Calcium antagonists for congestive heart failure: evolving concepts in bridge building.

M Packer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8485073     DOI： 10.1007/bf00878315

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  8 in total

1.  The effect of diltiazem on mortality and reinfarction after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

2.  A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.

Authors:  U Elkayam; J Amin; A Mehra; J Vasquez; L Weber; S H Rahimtoola
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

3.  Long-term clinical, hemodynamic, angiographic, and neurohumoral responses to vasodilation with felodipine in patients with chronic congestive heart failure.

Authors:  E Kassis; O Amtorp
Journal:  J Cardiovasc Pharmacol       Date:  1990-03       Impact factor: 3.105

4.  Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects.

Authors:  L B Tan; R G Murray; W A Littler
Journal:  Br Heart J       Date:  1987-08

5.  Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure.

Authors:  J N Barjon; J L Rouleau; D Bichet; C Juneau; J De Champlain
Journal:  J Am Coll Cardiol       Date:  1987-03       Impact factor: 24.094

6.  Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.

Authors:  R E Goldstein; S J Boccuzzi; D Cruess; S Nattel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

Review 7.  Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure.

Authors:  M Packer
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

8.  Efficacy of felodipine in congestive heart failure.

Authors:  P H Dunselman; C E Kuntze; A van Bruggen; J P Hamer; A H Scaf; H Wessling; K I Lie
Journal:  Eur Heart J       Date:  1989-04       Impact factor: 29.983
  8 in total
  7 in total

1.  Relationship of changes in felodipine pharmacokinetics to haemodynamics during chronic oral treatment of congestive heart failure patients.

Authors:  A H Scaf; P H Dunselman; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 2.  Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.

Authors:  M Haria; A J Wagstaff
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 3.  Cardioselectivity of calcium antagonists.

Authors:  T Godfraind
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 4.  Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine.

Authors:  W C Little; C P Cheng; L Elvelin; M Nordlander
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

5.  Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study.

Authors:  M Hori; H Sato; M Karita; K Kodama; N Hoki; T Hayashi; M Naka; S Nanto; Y Yamada; T Kamada
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

Review 6.  ACE inhibitors and calcium antagonists in the treatment of congestive heart failure.

Authors:  J F Hansen
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

7.  Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.

Authors:  W A Littler; D J Sheridan
Journal:  Br Heart J       Date:  1995-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.